Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).

Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman D.

CNS Drug Rev. 2006 Spring;12(1):21-38. Review.

2.

Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.

Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, Martin BR.

Biochem Biophys Res Commun. 2001 Feb 23;281(2):444-51.

PMID:
11181068
3.

Cannabinoid properties of methylfluorophosphonate analogs.

Martin BR, Beletskaya I, Patrick G, Jefferson R, Winckler R, Deutsch DG, Di Marzo V, Dasse O, Mahadevan A, Razdan RK.

J Pharmacol Exp Ther. 2000 Sep;294(3):1209-18.

PMID:
10945879

Supplemental Content

Support Center